Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05749939 · ClinicalTrials.gov registry record · Phase 3

Acceptance Commitment Therapy for Caregivers of People with Memory Loss

A Phase 3 study, sponsored by Utah State University.

Completed
Registry status
Phase 3
Development phase
121
Enrollment target

NCT05749939 is a Phase 3 study that has completed, run by Utah State University. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05749939, a Phase 3 study, has completed, sponsored by Utah State University.

COMPLETED
Registry status
Phase 3
Development phase
121 participants
Enrollment target

Study Summary

Family caregivers for persons with dementia report high levels of depression, stress, and burden. Caregivers' limited time, transportation constraints, and unpredictable schedules make on-line, self-guided interventions more accessible and scalable. Acceptance and Commitment Therapy (ACT) is an established and effective in-person therapy, well-suited to the dementia care giving context where caregivers cannot minimize stress exposure, and report difficult thoughts and emotions. ACT for Caregivers is an on-line self-guided ACT intervention that showed effectiveness in a Stage I pilot (n=52) with participants reporting decreased depressive symptoms, stressful reactions to caring, and caregiver burden, and increased quality of life and positive aspects of caring (all p \<.05). Learning from the pilot, the current Stage III intervention will shorten the program from 10 sessions to 6 sessions. The investigators introduce a wait list randomized control trial (RCT) design with fully longitudinal mixed methods to evaluate ACT for Caregivers. Data will be collected at pretest, post-test, and 6-weeks follow-up. Study aims are: 1) to evaluate ACT for Caregivers in a larger sample using an RCT, 2) to understand user experiences and the process of change by collecting short response data from all participants at all time points and interviewing a subset of participants in-depth at two time points, 3) to integrate quantitative and qualitative findings and examine areas of convergence and divergence. This project offers a promising prevention and intervention program to support family caregivers that is scalable, at low cost and with high impact.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2023-02-16
Est. Completion 2024-01-21
Phase Phase 3

Sponsor

Utah State University

27 total trials

What the Registry Record Tells You About NCT05749939

The ClinicalTrials.gov registry entry for NCT05749939 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT05749939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05749939 about?

NCT05749939 is a clinical study titled "Acceptance Commitment Therapy for Caregivers of People with Memory Loss". Family caregivers for persons with dementia report high levels of depression, stress, and burden. Caregivers' limited time, transportation constraints, and unpredictable schedules make on-line, self-guided interventions more accessible and scalable. Acceptance and Commitment Therapy (ACT) is an esta...

What is the current status of trial NCT05749939?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 121 participants. The study started on 2023-02-16. Estimated completion is 2024-01-21.

What interventions are being tested in trial NCT05749939?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05749939?

This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.